Idiopathic Intracranial Hypertension Clinical Trial
Official title:
Outcome of Cerebral Venous Sinuses Stenting on Idiopathic Intracranial Hypertension
The aim of the work is to asses the positive effect of stenotic sinus segment stenting on idiopathic intracranial hypertension with headache and papilloedema.
Participants The study will include group of patients with an established diagnosis of idiopathic intracranial hypertenton meeting our inclusion criteria and will admitted to Al-Azher Univerity Hospitals (Al-Hussien and Bab El-Shaeria) after informed consent from them. The recruitment will take place after approval from the Ethics Committee and the University Council. - They are selected according to The modified Dandy Criteria to Diagnose IIH: 1. Grade II paplledema . 2. normal neurological examination except for six nerve palsy. 3. neuroimaging criteria of normal brain parenchyma without evidence of hydrocephalus, mass or structural lesion and no abnormal meningeal enhancement on MRI. 4. normal CSF composition. 5. elevated lumbar puncture opening pressure, defined as greater than or equal to 250 mmH2O in adults (7). - Exclusion criteria included: 1. Age less than orequal to 18 years. 2. creatinine .1.5 mg/dL. 3. severe allergic reaction to iodine contrast. 4. contraindication to general anesthesia, use of aspirin, clopidogrel or anticoagulants, thrombophilic disorder or anticardiolipin syndrome. 5. dural arteriovenous fistula or other arteriovenous lesion affecting cortical venous flow. 6. pregnancy. 7. Blood pressure must be measured to exclude malignant hypertension, as defined as a diastolic blood pressure greater than or equal to 120 mm Hg or systolic blood pressure greater than or equal to 180 mm Hg(17). ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT01863381 -
Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement
|
N/A | |
| Recruiting |
NCT06027567 -
The Effect of an Anti-obesity Drug, Semaglutide, as Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (Dietician) With Regards to Change in Weight and Intracranial Pressure
|
Phase 4 | |
| Active, not recruiting |
NCT02896452 -
Astronaut Vision Issues in a Ground Analog Population: Polycystic Ovary Syndrome
|
||
| Recruiting |
NCT06059703 -
Biomarkers in the Etiology of Idiopathic Intracranial Hypertension
|
N/A | |
| Terminated |
NCT05347147 -
A Trial to Determine the Efficacy and Safety of Presendin in IIH
|
Phase 3 | |
| Not yet recruiting |
NCT06361823 -
Exploratory Study on the Efficacy and Safety of Semaglutide for Idiopathic Intracranial Hypertension Treatment
|
Phase 3 | |
| Active, not recruiting |
NCT02124486 -
An RCT of Bariatric Surgery vs a Community Weight Loss Programme for the Sustained Treatment of IIH
|
N/A | |
| Recruiting |
NCT02143258 -
Stenting of Venous Sinus Stenosis for Medically Refractory Idiopathic Intracranial Hypertension
|
N/A | |
| Not yet recruiting |
NCT05762367 -
MR Lymphatic Imaging in Idiopathic Intracranial Hypertention
|
N/A | |
| Not yet recruiting |
NCT06436820 -
ICP & Outflow Study
|
||
| Completed |
NCT03867461 -
The Effects of MAP and EtCO2 on Venous Sinus Pressures
|
N/A | |
| Completed |
NCT03963336 -
Quantitative D-dimer Level and Anticoagulant Therapy in Idiopathic Intracranial Hypertension
|
Early Phase 1 | |
| Completed |
NCT01003639 -
Idiopathic Intracranial Hypertension Treatment Trial
|
Phase 2/Phase 3 | |
| Recruiting |
NCT03096743 -
Evaluating Raised Intracranial Pressure Using MR Elastography
|
N/A | |
| Completed |
NCT04314128 -
Assessment of ICP in Idiopathic Intracranial Hypertension Using Transocular Ultrasound and Transcranial Doppler
|
N/A | |
| Terminated |
NCT03501966 -
Surgical Idiopathic Intracranial Hypertension Treatment Trial
|
Phase 3 | |
| Active, not recruiting |
NCT03556085 -
Venous Sinus Stenting With the River Stent in IIH
|
N/A | |
| Completed |
NCT02017444 -
Safety and Effectiveness of 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) to Treat Idiopathic Intracranial Hypertension.
|
Phase 2 |